As of 30 Sep 2025, 20 institutional investors reported holding $561,598,000 in principal (par value) of NOVOCURE LTD - NOTE 11/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $561,598,000 | $558,197,754 | +$18,421,677 | 99.27% | 20 |
| 2025 Q2 | $555,717,000 | $543,772,521 | -$6,061,249 | 97.8% | 23 |
| 2025 Q1 | $550,788,000 | $535,795,286 | -$2,906,097,114 | 96.62% | 17 |
| 2024 Q4 | $552,975,000 | $528,290,962 | -$17,361,963 | 95.49% | 17 |
| 2024 Q3 | $571,249,000 | $539,561,712 | +$370,461 | 94.39% | 18 |
| 2024 Q2 | $570,899,000 | $525,612,433 | -$7,854,814 | 92.06% | 18 |
| 2024 Q1 | $580,224,000 | $530,625,512 | +$17,847,998 | 91.15% | 23 |
| 2023 Q4 | $69,990,000 | $60,758,319 | 86.81% | 1 | |
| 2023 Q3 | $489,024,992 | $440,592,412 | +$24,758,617 | 86.07% | 23 |
| 2023 Q2 | $458,119,374 | $420,411,974 | +$24,600,487 | 86.25% | 31 |
| 2023 Q1 | $425,408,987 | $392,526,666 | -$24,151,172,043 | 86.53% | 30 |
| 2022 Q4 | $466,618,086 | $431,129,973 | +$13,185,553 | 89.19% | 31 |
| 2022 Q3 | $324,223,478 | $293,596,091 | -$61,471,891 | 88.78% | 30 |
| 2022 Q2 | $396,558,347 | $362,603,665 | -$35,897,004,866 | 86.62% | 32 |
| 2022 Q1 | $546,744,600 | $502,538,798 | +$13,433,131 | 91.13% | 44 |
| 2021 Q4 | $515,788,680 | $486,897,748 | +$486,895,635 | 91.88% | 38 |